Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Altrazeal Silver is a silver-containing variant of the Altrazeal transforming powder dressing, a methacrylate-based nanoparticle wound dressing engineered to hydrate and aggregate into a conforming, oxygen-permeable matrix that provides a moist wound environment, manages exudate, and forms a physical barrier against external microorganisms to support granulation and re-epithelialization. Building on the base Altrazeal technology, the Silver formulation incorporates topical silver as an antimicrobial agent to reduce bioburden in exuding wounds while maintaining extended wear time and atraumatic dressing changes. It is intended for professional wound care use in a range of acute and chronic wounds where both advanced moisture management and local antimicrobial activity are desired.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Altrazeal Silver.